Roy D. Altman
Impact in
- Rheumatology top 0.01%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Orthopedics and Sports Medicine top 0.2%
- Tendon Structure and Treatment
Papers in
- Rheumatology 152
- Osteoarthritis Treatment and Mechanisms 119
- Rheumatoid Arthritis Research and Therapies 33
- Bone Tumor Diagnosis and Treatments 8
- Pharmacology 51
- Inflammatory mediators and NSAID effects 47
- Co-authors
- Marc C. Hochberg (27 shared papers)Roland W. Moskowitz (11 shared papers)Garry E. Gold (3 shared papers)Peter Tugwell (5 shared papers)Stefan Lohmander (7 shared papers)Maxime Dougados (5 shared papers)K D Brandt (4 shared papers)Weiya Zhang (6 shared papers)
- Journals
- Osteoarthritis and Cartilage (34 papers)Seminars in Arthritis and Rheumatism (27 papers)Cartilage (8 papers)Annals of the Rheumatic Diseases (6 papers)The American Journal of Medicine (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Roy D. Altman
243 papers receiving 22.2k citations
Roy D. Altman's Hit Papers
Peers
Comparison fields: 5 of 176
- Rheumatology 11.4k
- Orthopedics and Sports Medicine 2.1k
- Pharmacology 3.6k
- Urology 650
- Surgery 4.6k
Countries citing papers authored by Roy D. Altman
This map shows the geographic impact of Roy D. Altman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy D. Altman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy D. Altman more than expected).
Fields of papers citing papers by Roy D. Altman
This network shows the impact of papers produced by Roy D. Altman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy D. Altman. The network helps show where Roy D. Altman may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy D. Altman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 245 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee Hit paper breakdown → | 2012 | 2183 |
| 2 | OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines Hit paper breakdown → | 2008 | 2148 |
| 3 | OARSI recommendations for the management of hip and knee osteoarthritis Hit paper breakdown → | 2010 | 1257 |
| 4 | Atlas of individual radiographic features in osteoarthritis, revised Hit paper breakdown → | 2007 | 1103 |
| 5 | Guidelines for the medical management of osteoarthritis Hit paper breakdown → | 1995 | 787 |
| 6 | OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Hit paper breakdown → | 2004 | 669 |
| 7 | Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. Hit paper breakdown → | 1997 | 618 |
| 8 | OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence Hit paper breakdown → | 2007 | 591 |
| 9 | Guidelines for the medical management of osteoarthritis Hit paper breakdown → | 1995 | 552 |
| 10 | Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society Hit paper breakdown → | 1996 | 471 |
| 11 | 2004 | 454 | |
| 12 | Atlas of individual radiographic features in osteoarthritis. | 1995 | 398 |
| 13 | Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. | 1998 | 381 |
| 14 | Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology Hit paper breakdown → | 2015 | 368 |
| 15 | 2001 | 355 | |
| 16 | 1987 | 319 | |
| 17 | 2005 | 311 | |
| 18 | Criteria for classification of clinical osteoarthritis. | 1991 | 250 |
| 19 | 2014 | 238 | |
| 20 | 1991 | 232 |
About Roy D. Altman
Roy D. Altman is a scholar working on Rheumatology, Pharmacology, Surgery, Orthopedics and Sports Medicine and Oncology, having authored 245 papers that have together received 23.3k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (119 papers), Inflammatory mediators and NSAID effects (47 papers), Rheumatoid Arthritis Research and Therapies (33 papers), Bone health and treatments (16 papers), Tendon Structure and Treatment (11 papers), Total Knee Arthroplasty Outcomes (10 papers), Knee injuries and reconstruction techniques (8 papers) and Bone Tumor Diagnosis and Treatments (8 papers). The work is most often cited by research in Rheumatology (11.4k citations), Orthopedics and Sports Medicine (2.1k citations), Pharmacology (3.6k citations), Urology (650 citations) and Surgery (4.6k citations). Roy D. Altman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc C. Hochberg, Roland W. Moskowitz, Garry E. Gold, Peter Tugwell, Stefan Lohmander, Maxime Dougados, K D Brandt, Weiya Zhang, Michael Doherty and David J. Hunter. Their work appears in journals such as Osteoarthritis and Cartilage, Seminars in Arthritis and Rheumatism, Cartilage, Annals of the Rheumatic Diseases and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.